These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31479743)

  • 1. Daptomycin resistance in methicillin-resistant Staphylococcus aureus is conferred by IS256 insertion in the promoter of mprF along with mutations in mprF and walK.
    Yin Y; Chen H; Li S; Gao H; Sun S; Li H; Wang R; Jin L; Liu Y; Wang H
    Int J Antimicrob Agents; 2019 Dec; 54(6):673-680. PubMed ID: 31479743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of compensatory mutations associated with restoration of daptomycin-susceptibility in daptomycin non-susceptible methicillin-resistant Staphylococcus aureus and the role mprF mutations.
    Kanesaka I; Fujisaki S; Aiba Y; Watanabe S; Mikawa T; Katsuse AK; Takahashi H; Cui L; Kobayashi I
    J Infect Chemother; 2019 Jan; 25(1):1-5. PubMed ID: 30322736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of mprF mutations with cross-resistance to daptomycin and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA).
    Thitiananpakorn K; Aiba Y; Tan XE; Watanabe S; Kiga K; Sato'o Y; Boonsiri T; Li FY; Sasahara T; Taki Y; Azam AH; Zhang Y; Cui L
    Sci Rep; 2020 Sep; 10(1):16107. PubMed ID: 32999359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency and Distribution of Single-Nucleotide Polymorphisms within mprF in Methicillin-Resistant Staphylococcus aureus Clinical Isolates and Their Role in Cross-Resistance to Daptomycin and Host Defense Antimicrobial Peptides.
    Bayer AS; Mishra NN; Chen L; Kreiswirth BN; Rubio A; Yang SJ
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4930-7. PubMed ID: 26055370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of mprF sequences in methicillin-resistant Staphylococcus aureus clinical isolates: role in cross-resistance between daptomycin and host defense antimicrobial peptides.
    Bayer AS; Mishra NN; Sakoulas G; Nonejuie P; Nast CC; Pogliano J; Chen KT; Ellison SN; Yeaman MR; Yang SJ
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7462-7. PubMed ID: 25288091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VraSR two-component regulatory system contributes to mprF-mediated decreased susceptibility to daptomycin in in vivo-selected clinical strains of methicillin-resistant Staphylococcus aureus.
    Mehta S; Cuirolo AX; Plata KB; Riosa S; Silverman JA; Rubio A; Rosato RR; Rosato AE
    Antimicrob Agents Chemother; 2012 Jan; 56(1):92-102. PubMed ID: 21986832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of daptomycin resistance in daptomycin-naïve rabbits with methicillin-resistant Staphylococcus aureus prosthetic joint infection is associated with resistance to host defense cationic peptides and mprF polymorphisms.
    Mishra NN; Yang SJ; Chen L; Muller C; Saleh-Mghir A; Kuhn S; Peschel A; Yeaman MR; Nast CC; Kreiswirth BN; Crémieux AC; Bayer AS
    PLoS One; 2013; 8(8):e71151. PubMed ID: 23990934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gain-of-Function Mutations in the Phospholipid Flippase MprF Confer Specific Daptomycin Resistance.
    Ernst CM; Slavetinsky CJ; Kuhn S; Hauser JN; Nega M; Mishra NN; Gekeler C; Bayer AS; Peschel A
    mBio; 2018 Dec; 9(6):. PubMed ID: 30563904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of
    Jiang S; Zhuang H; Zhu F; Wei X; Zhang J; Sun L; Ji S; Wang H; Wu D; Zhao F; Yan R; Yu Y; Chen Y
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0129521. PubMed ID: 34662187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MprF-mediated daptomycin resistance.
    Ernst CM; Peschel A
    Int J Med Microbiol; 2019 Jul; 309(5):359-363. PubMed ID: 31182276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Daptomycin Tolerance and Resistance Mutations in Methicillin-Resistant Staphylococcus aureus from Adaptive Laboratory Evolution.
    Sulaiman JE; Lam H
    mSphere; 2021 Oct; 6(5):e0069221. PubMed ID: 34585959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic and genotypic correlates of daptomycin-resistant methicillin-susceptible Staphylococcus aureus clinical isolates.
    Kang KM; Mishra NN; Park KT; Lee GY; Park YH; Bayer AS; Yang SJ
    J Microbiol; 2017 Feb; 55(2):153-159. PubMed ID: 28120188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single nucleotide polymorphism leads to daptomycin resistance causing amino acid substitution-T345I in MprF of clinically isolated MRSA strains.
    Nakamura M; Kawada H; Uchida H; Takagi Y; Obata S; Eda R; Hanaki H; Kitasato H
    PLoS One; 2021; 16(1):e0245732. PubMed ID: 33481910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-genome sequencing identifies MprF mutations in a genetically diverse population of daptomycin non-susceptible Staphylococcus aureus in Australia.
    Lim C; Coombs GW; Daley DA; Shoby P; Mowlaboccus S
    Int J Antimicrob Agents; 2024 May; 63(5):107144. PubMed ID: 38494147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased vancomycin susceptibility in Staphylococcus aureus caused by IS256 tempering of WalKR expression.
    McEvoy CR; Tsuji B; Gao W; Seemann T; Porter JL; Doig K; Ngo D; Howden BP; Stinear TP
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3240-9. PubMed ID: 23629723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulation of mprF and dltABCD expression among daptomycin-non-susceptible MRSA clinical isolates.
    Bayer AS; Mishra NN; Cheung AL; Rubio A; Yang SJ
    J Antimicrob Chemother; 2016 Aug; 71(8):2100-4. PubMed ID: 27121398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. dltA overexpression: A strain-independent keystone of daptomycin resistance in methicillin-resistant Staphylococcus aureus.
    Cafiso V; Bertuccio T; Purrello S; Campanile F; Mammina C; Sartor A; Raglio A; Stefani S
    Int J Antimicrob Agents; 2014 Jan; 43(1):26-31. PubMed ID: 24183798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin tolerance in methicillin-resistant Staphylococcus aureus: influence of vancomycin, daptomycin, and telavancin on differential resistance gene expression.
    Rose WE; Fallon M; Moran JJ; Vanderloo JP
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4422-7. PubMed ID: 22687502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged Exposure to β-Lactam Antibiotics Reestablishes Susceptibility of Daptomycin-Nonsusceptible Staphylococcus aureus to Daptomycin.
    Jenson RE; Baines SL; Howden BP; Mishra NN; Farah S; Lew C; Berti AD; Shukla SK; Bayer AS; Rose WE
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32601160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo development of daptomycin resistance in vancomycin-susceptible methicillin-resistant Staphylococcus aureus severe infections previously treated with glycopeptides.
    Capone A; Cafiso V; Campanile F; Parisi G; Mariani B; Petrosillo N; Stefani S
    Eur J Clin Microbiol Infect Dis; 2016 Apr; 35(4):625-31. PubMed ID: 26815434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.